A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
A Study to Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma
- Status
- COMPLETED
- Phase
- N/A
Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis
- Status
- COMPLETED
- Phase
- NA
Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
- Status
- COMPLETED
- Phase
- PHASE3
Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of an Etoricoxib and Tizanidine Fixed Dose Combination in Participants With Moderate to Severe Acute Low Back Pain (MK-0663B-164)
- Status
- WITHDRAWN
- Phase
- PHASE3
Advanced Neuroimaging Evaluation of CNS Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen
- Status
- COMPLETED
- Phase
- NA
Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Biomarkers of Anti-TNF Treatment in Inflammatory Bowel Disease (IBD)
- Status
- COMPLETED
- Phase
- N/A
Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003)
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugammadex
- Status
- COMPLETED
- Phase
- NA
Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)
- Status
- COMPLETED
- Phase
- PHASE1
An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq)
- Status
- COMPLETED
- Phase
- PHASE4
A High Density EEG Comparison of Sleep Patterns in Insomnia
- Status
- COMPLETED
- Phase
- N/A
Adolescent Vaccination in Pharmacies
- Status
- COMPLETED
- Phase
- N/A
A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)
- Status
- COMPLETED
- Phase
- PHASE3
Metabolomics of Insomnia-Related Hyperarousal
- Status
- COMPLETED
- Phase
- N/A
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)
- Status
- COMPLETED
- Phase
- PHASE1